ILSI Threshold of Toxicological Concern
Nano exposure monitoring
ER_Nanotechnology_Report.pdf
JLab Nano-materials Program Kevin Jordan PE [email protected] August 12, 2008.
Imatinib pre-clinical and clinical development Stephen Oh, M.D, Ph.D. Markey Program October 30, 2014.
DLA Strategic Materials Hazard Communication (HazCom) Program May 2015 Hard copies of this document may not be the current version. Refer to the “I Am.
DIOXINS: ARE WE ALL AT RISK? Linda. S. Birnbaum, PhD, DABT National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency.
JLab Nano -materials Program